Company history

The founders of Corimmun GmbH have laid the foundations to most current projects with a first platform technology company, Procorde GmbH, in 2000. From 2007 on, a significant financing of the successor company, Corimmun GmbH, enabled further clinical development of the most promising drugs, which had been identified by using these technologies.

The company has been continuously managed by experienced Biotech entrepreneurs. Several big pharma cooperations have been successfully completed (e.g. with Aventis). Besides, award-winning projects were granted, e.g. from the Go-Bio program of the German ministry of science and education (BMBF).